195 related articles for article (PubMed ID: 29479446)
1. Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report.
Macau RA; da Silva TN; Silva JR; Ferreira AG; Bravo P
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29479446
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
3. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
4. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Inoue M; Nakai K; Mitsuiki K
CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
[TBL] [Abstract][Full Text] [Related]
5. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
[TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Lithium-induced Partial Nephrogenic Diabetes Insipidus.
Rauf A; Gul S; Nasir M; Arif U; Oyenuga M
Cureus; 2020 Apr; 12(4):e7877. PubMed ID: 32489731
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic diabetes insipidus: a comprehensive overview.
Vaz de Castro PAS; Bitencourt L; de Oliveira Campos JL; Fischer BL; Soares de Brito SBC; Soares BS; Drummond JB; Simões E Silva AC
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):421-434. PubMed ID: 35146976
[TBL] [Abstract][Full Text] [Related]
8. Congenital nephrogenic diabetes insipidus treated with acetazolamide.
Du Plessis W; Chothia MY
Nephrology (Carlton); 2024 Jul; 29(7):438-441. PubMed ID: 38450903
[TBL] [Abstract][Full Text] [Related]
9. [Water, lithium and sodium: watch out for dangerous injuries].
Fayolle M; Souweine JS; Mathieu O; Bargnoux AS; Cristol JP; Badiou S
Ann Biol Clin (Paris); 2020 Aug; 78(4):449-453. PubMed ID: 32618565
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
[TBL] [Abstract][Full Text] [Related]
11. [Lithium-induced nephrogenic diabetes insipidus during acute intoxication: a case report].
Echater S; Hasnaoui M; Lechner E
Pan Afr Med J; 2023; 45():77. PubMed ID: 37663626
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeutic Option.
Hashikawa R; Yamada H; Fujii T; Ohtsuru S
Am J Case Rep; 2024 Apr; 25():e943244. PubMed ID: 38643357
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy.
Kamath C; Govindan J; Premawardhana AD; Wood SJ; Adlan MA; Premawardhana LD
Clin Med (Lond); 2013 Aug; 13(4):407-10. PubMed ID: 23908517
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe lithium-induced polyuria with amiloride.
Kosten TR; Forrest JN
Am J Psychiatry; 1986 Dec; 143(12):1563-8. PubMed ID: 3538913
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lithium-induced diabetes insipidus with amiloride.
Finch CK; Kelley KW; Williams RB
Pharmacotherapy; 2003 Apr; 23(4):546-50. PubMed ID: 12680486
[TBL] [Abstract][Full Text] [Related]
16. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
17. Persistent nephrogenic diabetes insipidus following lithium therapy.
Thompson CJ; France AJ; Baylis PH
Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
[TBL] [Abstract][Full Text] [Related]
19. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
Posner L; Mokrzycki MH
Am J Nephrol; 1996; 16(4):339-43. PubMed ID: 8739289
[TBL] [Abstract][Full Text] [Related]
20. Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report.
Takayasu S; Kamba A; Yoshida K; Terui K; Watanuki Y; Ishigame N; Mizushiri S; Tomita T; Nakamura K; Yasui-Furukori N; Daimon M
BMC Nephrol; 2020 May; 21(1):157. PubMed ID: 32357847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
